San Diego-based genetic analysis company Sequenom Inc. announced that its subsidiary, the Sequenom Center for Molecular Medicine, has built another laboratory in North Carolina.
The new lab, in Raleigh-Durham, is currently processing patient samples with Sequenom’s MaterniT21 PLUS tests. It said it can process 100,000 tests per year, increasing the company’s total capacity to 300,000 test samples per year.
The MaterniT21 prenatal test evaluates whether a fetus has Down syndrome or other chromosomal abnormalities as early as 10 weeks of pregnancy.
“We are excited about the opening in North Carolina of our third U.S.-based laboratory location,” Sequenom president and COO William Welch said in a statement. “Our investment in establishing this new presence on the East Coast will allow us to better meet the needs of health care providers by providing critical additional capacity and geographic backup needed to address the rapidly growing adoption of our testing services.”
— SDBJ Staff Report